M&A Corner
Hera Biotech to Make First Acquisition in the Endometriosis Diagnostic Market and Enter into Strategic Partnership with Scailyte.09 Jan 2024
Hera Biotech plans to acquire Scailyte’s endometriosis diagnostic assets, consolidating tissue-based programs for the disorder. The move aims to revolutionize... Continue Reading
|
Biopharma Closes 2023 with Flurry of M&A Activity from AstraZeneca, BMS, Roche09 Jan 2024
The biopharma sector concluded 2023 with notable acquisitions in oncology, autoimmune diseases, radiopharmaceuticals, and diagnostics. AstraZeneca acquired Gracell Biotechnologies for... Continue Reading
|
Novanta Completes Acquisition of Motion Solutions09 Jan 2024
Novanta Inc. (Nasdaq: NOVT) has finalized the acquisition of Motion Solutions, aligning with its focus on precision technology for medical... Continue Reading
|
Calibre Scientific Acquires LineaLAB09 Jan 2024
Calibre Scientific has acquired LineaLAB, strengthening its presence in Spain’s laboratory market. The purchase includes LineaLAB’s extensive range of high-quality... Continue Reading
|
Enpro Inc. to Acquire Advanced Micro Instruments, Inc.02 Jan 2024
Enpro Inc. announced its acquisition of Advanced Micro Instruments (AMI) for $210 million. AMI, a provider of specialized analyzers, monitors... Continue Reading
|
Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic’s Proposed Merger with Standard BioTools02 Jan 2024
Dr. Larry Gold and Dr. Jason Cleveland, key figures at SomaLogic, express opposition to the company’s merger with Standard BioTools.... Continue Reading
|
Lilly Completes Acquisition of POINT Biopharma02 Jan 2024
Eli Lilly finalizes its acquisition of POINT Biopharma, specializing in radioligand therapies for cancer treatment. With 67.97% of shares tendered... Continue Reading
|
Constellation Software Acquires MEDHOST, Bolstering Healthcare Portfolio02 Jan 2024
Constellation Software’s N. Harris Computer Corporation acquires MEDHOST, Inc., a leading provider of tailored EHR solutions for ambulatory care. MEDHOST’s... Continue Reading
|
Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.02 Jan 2024
Cyclo Therapeutics and Applied Molecular Transport finalize their all-stock merger, forming a combined entity under Cyclo Therapeutics, Inc. The company... Continue Reading
|
Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp02 Jan 2024
Visiox Pharmaceuticals and PowerUp Acquisition Corp. confirm a definitive agreement for a business merger, intending to take Visiox public on... Continue Reading
|